Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors

US8067599B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Konrad Honold · Penzberg, DE
• Wolfgang Schaefer · Sankt Augustin, DE
• Stefan Scheiblich · Mainz, DE

Key dates

• Filing date: Sep 4, 2007
• Grant date: Nov 29, 2011
• Expiry date: Oct 1, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Objects of the present invention are the compounds of formula Itheir pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.